Oncotarget
International Tumor Board Explores Personalized Treatment Strategies for Colon Cancer Without Measurable Disease
9:27
BUFFALO, NY - October 26, 2026 – A new #casereport was #published in Volume 17 of Oncotarget on October 16, 2026, titled “WIN-MTB-2024002 – WIN International Molecular Tumor Board: A 52-year-old female with unmeasurable Stage IIIc colon cancer.” The report describes a 52-year-old woman with stage IIIc colon cancer whose disease remained difficult to monitor despite extensive treatment. Although…